SOURCES : [1] Blume-Peytavi, U
But after two months, she stopped taking them because they made her feel sick
Obesity 32(1):5058 Colbourne JR et al (2023) The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery
There are a number of methods to reduce the out-of-pocket cost of these drugs, including subsidies and increasing insurance coverage, but Govind Persad of the University of Colorado Law School noted that it is also critical to ensure that incentivesmany of which are monetaryremain for drug developers to continue to innovate in this field while simultaneously maximizing patient access now
Most trials focus on intermediate outcomes such as weight, fat mass, exercise markers, or cognition
October 15, 2025: State Lawsuits Accuse Eli Lilly of Downplaying Trulicity Side Effects About 40 lawsuits filed in Indiana accuse Eli Lilly of downplaying the risks of its GLP-1 drugs, like Trulicity